Many drivers are unknowingly breaking the law by failing to give pedestrians priority at junctions — and cyclists at roundabouts — potentially putting other road users in danger and leaving themselves ...
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results